Specifications TableSubjectParasitologySpecific subject area*In vitro* culture systemsType of dataTableHow data were acquiredMicroscopyData formatRaw and analysedParameters for data collection*In vitro* cultures were performed by culturing 30--50 microfilariae/well in a 48-well flat-bottomed plate with or without a confluent monolayer of monkey kidney epithelial cells (LLC-MK~2~) as feeder cells in either RPMI-1640 or DMEM media supplemented with 5 μg/ml ciprofloxacin and 10 μg/ml fluconazole in the presence or absence of 10% fetal bovine serum (FBS).Description of data collectionMicrofilariae motility was scored daily using microscopy (x10 magnification) by applying a 4-point grading scale: 0, no movement or immotile; 1, intermittent shaking of head and tail; 2, sluggish (shaking of the whole form whilst the microfilariae remain stationary); 3, vigorous movement (shaking of the whole form with migration around the well).Data accessibilityWithin the articleRelated research articleNjouendou AJ, Kien CA, Esum ME, Ritter M, Chounna Ndongmo WP, Fombad FF, Gandjui NVT, Njiokou F, Enyong P, Pfarr K, Turner J, Layland LE, Hoerauf A, Wanji S. "*In vitro* maintenance of *Mansonella perstans* microfilariae and its relevance for drug screening." Experimental Parasitology 2019; DOI: <https://doi.org/10.1016/j.exppara.2019.107769>**Value of the Data**•Scoring of microfilariae motility will be useful for the assessment of suitable conditions for filarial survival as well as testing drug efficacy.•Data presented here can be used as reference for further culture of *M. perstans* Mf.•Data processing approaches of these datasets is easy to replicate and relevant for the comparative analysis of the motility of filarial species *in vitro.*•The dataset supplied with this article can be subsequently used for meta-analysis.•The described analytical approach will be useful to assess the efficacy of chemotherapeutic agents against Mf.

1. Data {#sec1}
=======

The findings presented here are based on the previous publication entilted "*In vitro* maintenance of *Mansonella perstans* microfilariae and its relevance for drug screening" \[[@bib1]\]. Data on the optimization of the *in vitro* culture conditions for the maintenance of *M. perstans* Mf are summarized in [Table 1](#tbl1){ref-type="table"} (RPMI-1640) and [Table 2](#tbl2){ref-type="table"} (DMEM), showing the daily average motility and areas under the curve (AUC) of *M. perstans* Mf activity.Table 1Average motility and area under the curve (AUC) of *M. perstans* Mf activity during *in vitro* cultures containing RPMI-1640 medium supplemented with or without 10% fetal bovine serum (FBS) and/or monkey kidney epithelial feeder cells (LLC-MK~2~) over 20 days.Table 1Incubation daysCell-freeLLC-MK~2~Serum-free10% FBSSerum-free10% FBS0100100100100199.5899.310099.78281.0298.29100100372.2595.76100100441.8684.84100100528.4682.31100100626.580.68100100725.3679.1100100825.3679.1100100925.2479.11001001025.2479.11001001125.2479.11001001225.2479.11001001325.2479.110099.631425.2479.11001001525.2479.110099.621625.2479.110099.631725.2479.110099.461825.2479.110099.461925.3878.7310099.462025.3878.7310099.46**Average AUC (%)**37.0482.9210099.84*p-*value[a](#tbl1fna){ref-type="table-fn"}--0.26230.00030.0034[^2][^3]Table 2Average motility and area under the curve (AUC) of *M. perstans* Mf activity during *in vitro* cultures containing DMEM medium supplemented with or without 10% fetal bovine serum (FBS) and/or monkey kidney epithelial feeder cells (LLC-MK~2~) over 20 days.Table 2Incubation daysCell-freeLLC-MK~2~Serum-free10% FBSSerum-free10% FBS0100100100100199.299.49100100299.398.8310099.76388.9795.1710099.76480.0487.4310099.76577.5584.4110099.76677.879.3710099.76777.6479.2610099.76877.5279.2610099.76977.7179.2610099.761077.7178.9910099.761177.7179.2610099.761277.7179.2610099.761377.7179.2610099.421477.7179.2699.7299.421577.7179.2610099.421677.7179.2610099.421777.7179.2610099.421877.7179.2610099.421977.7179.1310099.422077.7179.1310099.42**Average AUC (%)**81.0883.2199.9999.65*p-*value[a](#tbl2fna){ref-type="table-fn"}--0.9990.00410.0110[^4][^5]

2. Experimental design, materials, and methods {#sec2}
==============================================

*M. perstans* Mf extracted from human blood were cultured *in vitro* as recently described for *Loa loa* parasites \[[@bib2], [@bib3], [@bib4]\]. Briefly, 30--50 Mf/well were cultured in a 48-well flat-bottomed plate (Corning, New York, USA) with or without confluent monolayers of LLC-MK~2~ (LGC Standard GmbH, Wesel, Germany) as feeder cells in either RPMI-1640 or DMEM medium (Gibco, Cergy-Pontoise, France) supplemented with 5 μg/ml ciprofloxacin and 10 μg/ml fluconazole (Sigma Aldrich, St Louis, MO, USA) and in the presence or absence of 10% FBS (Lonza, Verviers, Belgium). Cultures were incubated at 37 °C and 5% CO~2~ for 20 days and helminth viability was evaluated by grading motility overtime. Mf motility was scored on a daily basis in a blind manner using x10 magnification with an inverted microscope (Motic, Wetzlar, Germany) by applying a 4-point scale:-0, no movement or immotile;-1, intermittent shaking of head and tail;-2, sluggish (shaking of the whole form whilst the Mf remain stationary);-3, vigorous movement (shaking of the whole form with migration around the well).

Raw data were saved in a spreadsheet and using the above described 4-point grading scale the percentage (%) of motility was calculated according to the following formula:$$\ \text{Motility~}\left( \text{\%} \right) = \frac{\sum\text{SiNi}}{3.\sum\text{Ni}} \times 100$$where Si is the score of point scale i and Ni is the total number of worms at a point scale I \[[@bib5]\].

The mean of the area under curve (AUC) was calculated using the percentage motility of the drugs from 0 to 5 days according to the following formula:$$\text{AUC}\  = \ \frac{\sum_{\text{i} = \text{0}}^{n - 1}{\left( {t_{i + 1} - t_{i}} \right)\left( {y_{i + 1} + y_{i}} \right)}}{t_{n - 1}}$$where AUC = area under curve; y = motility; t = time point; n = an integer \[[@bib6]\].

The effects of media and supplements on the Mf motility was compared using non-parametric tests. The Kruskal-Wallis one-way analysis test was used to assess the global significant differences between the median AUC and Dunn\'s post-hoc test was applied for pairwise multiple comparisons of the ranked data. This analysis was performed using the Pairwise Multiple Comparisons of Mean Rank Sums (*PMCMR*) package in R version 3.4.1 \[[@bib7]\].
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[^1]: Shared authorship.

[^2]: Abbreviations. AUC: area under the curve.

[^3]: Pairwise comparisons using Dunn\'s-test for multiple comparisons of independent samples. *p*-values presented in the table compare serum free and 10% FBS in the presence or absence of feeder cells (LLC MK~2~ cells).

[^4]: Abbreviations. AUC: area under the curve.

[^5]: Pairwise comparisons using Dunn\'s-test for multiple comparisons of independent samples. *p*-values presented in the table compare each system to the serum free and cell free system.
